Izumi Takei

TL;DR: The JDS extensively evaluated the usefulness and feasibility of more extended use of HbA1c in the diagnosis of diabetes based on Japanese epidemiological data, and then the ‘Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus’ was published in the Journal of Diabetes Investigation5 and Diabetology International.

TL;DR: It is suggested that pioglitazone exerts good glycemic and blood pressure control despite increased BMI and SAT in Japanese male patients with type 2 diabetes and may have an antiatherosclerotic effect by increasing serum adiponectin level.

TL;DR: Insulin intervention to preserve beta-cell function is effective and safe for patients with SPIDDM or latent autoimmune diabetes in adults.

TL;DR: The results show that the progression of autoimmune diseases in mice can effectively be suppressed by intramuscular DNA injection, and suggest that this method is potentially applicable to the treatment of human autoimmune diseases.

TL;DR: It is suggested that troglitazone may exert beneficial effects by reducing visceral fat, and a slight weight gain was associated with a tendency for subcutaneous fat to increase, while visceral fat decreased in both trog litazone-treated groups.